Department of Emergency Medicine, Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island, USA.
Emerg Med J. 2018 May;35(5):282-288. doi: 10.1136/emermed-2016-206540. Epub 2018 Feb 2.
Assess the 12-month efficacy of a brief intervention (BI) on reducing drug use and increasing drug treatment services utilisation among adult emergency department (ED) patients.
This randomised, controlled trial enrolled 18-64-year-old ED patients needing a drug use intervention. Treatment arm participants received a tailored BI while control arm participants only completed the study questionnaires. Self-reported past 3-month drug use and engagement in drug treatment services were compared by study arm at 3-month intervals over 1 year. Multiple imputations were performed to overcome loss-to-follow-up.
Of the 1030 participants, follow-up completion ranged 55%-64% over the four follow-ups. At 12 months, the two study arms were similar in regards to mean: (1) proportion reporting any drug use (treatment: 67.1% (61.6 to 72.6), control: 74.4% (69.4 to 79.4)); (2) drug use frequency on a five-point scale (treatment: 3.7 (3.3 to 4.2), control: 4.6 (4.0 to 5.2)); (3) total days of drug use (treatment: 28.3 (23.2 to 33.4), control: 33.4 (28.5 to 38.2)); (4) most number of times drugs used/day (treatment: 4.6 (3.6 to 5.5), control: 6.1 (4.8 to 7.3)) and (5) typical number of times drugs used/day (treatment: 3.3 (2.5 to 4.1), control: 5.1 (3.9 to 6.2)). Utilisation of drug treatment services also was similar by study arm. In multivariable regression analyses, patients who were homeless or had higher drug use at baseline continued to have greater drug use in follow-up.
Among adult ED patients requiring a drug use intervention, this BI did not decrease drug use or increase drug treatment services utilisation over a 12-month period more than the control condition.
NCT01124591; Pre-trial.
评估一项简短干预措施(BI)在减少成年急诊患者药物使用和增加药物治疗服务利用率方面的 12 个月疗效。
这项随机对照试验纳入了需要药物使用干预的 18-64 岁急诊患者。治疗组参与者接受了个性化的 BI,而对照组参与者仅完成了研究问卷。在 1 年内,通过研究组每隔 3 个月进行一次自我报告的过去 3 个月药物使用情况和药物治疗服务参与情况的比较。采用多重插补法克服失访。
在 1030 名参与者中,4 次随访的随访完成率在 55%-64%之间。在 12 个月时,两组研究组在以下方面相似:(1)报告任何药物使用的比例(治疗组:67.1%(61.6 至 72.6),对照组:74.4%(69.4 至 79.4%));(2)五分制药物使用频率(治疗组:3.7(3.3 至 4.2),对照组:4.6(4.0 至 5.2));(3)总药物使用天数(治疗组:28.3(23.2 至 33.4),对照组:33.4(28.5 至 38.2));(4)每日使用药物的最大次数(治疗组:4.6(3.6 至 5.5),对照组:6.1(4.8 至 7.3))和(5)每日使用药物的典型次数(治疗组:3.3(2.5 至 4.1),对照组:5.1(3.9 至 6.2))。药物治疗服务的利用情况也因研究组而异。在多变量回归分析中,无家可归或基线药物使用量较高的患者在随访中继续有更多的药物使用。
在需要药物使用干预的成年急诊患者中,与对照组相比,这种 BI 并没有在 12 个月内减少药物使用或增加药物治疗服务的利用率。
NCT01124591;预试验。